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Abstract Genetic analysis of a Drosophila synaptotagmin (Syt)
I mutant (AD3) has revealed that Tyr-334 within the C2B
domain is essential for efficient Ca2+-dependent neurotransmitter
release. However, little is known as to why a missense mutation
(Tyr-334-Asn) disrupts the function of the C2B domain at the
molecular level. Here, we present evidence that a Tyr-312 to Asn
substitution in mouse Syt II, which corresponds to the Drosophila
AD3 mutation, completely impairs Ca2+-dependent self-oligo-
merization activity mediated by the C2B domain but allows
partial interaction with wild-type proteins in a Ca2+-dependent
manner. This observation is consistent with the fact that the AD3
allele is homozygous lethal but complements another mutant
phenotype. We also showed that the Ca2+-dependent C2B self-
oligomerization is inhibited by inositol 1,3,4,5-tetrakisphosphate,
a potent inhibitor of neurotransmitter release. All of these
findings strongly support the idea that self-oligomerization of Syt
I or II is essential for neurotransmitter release in vivo. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
Key words: Synaptotagmin; C2 domain;
Self-oligomerization; Exocytosis; Synaptic vesicle
1. Introduction
Neurotransmission is now known to be achieved by a pro-
tein^protein cascade which is evolutionarily conserved from
nematoda to human (reviewed in [1]). Synaptotagmin I (Syt
I), an abundant synaptic vesicle protein, is one of the compo-
nents of this cascade and has been shown to be essential for
e⁄cient Ca2-dependent neurotransmitter release by analysis
of knock-out animals, such as mice [2], Drosophila [3], and
Caenorhabditis elegans [4]. Syt I consists of a short intravesic-
ular amino-terminus, a single transmembrane region, and two
highly conserved C2 domains (C2A and C2B) in the large
carboxyl-terminus (reviewed in [5^8]). Since the two C2 do-
mains interact with various molecules necessary for synaptic
vesicle exocytosis and endocytosis in vitro, including calcium
[9], phospholipids [10^15], inositol polyphosphates [12,16^18],
syntaxin [19], SNAP-25 [20,21], L-SNAP [22], SV2 [23], clath-
rin assembly protein, AP-2 [24], N- or P/Q-type calcium chan-
nels [25,26], SYNCRIP [27], or Syt I itself [28^34], the C2
domains are thought to be the functional domains of Syt I
in neurotransmitter release. Among these interactions, phos-
pholipid or syntaxin binding to the C2A domain and self-
oligomerization of the C2B domain are activated in the pres-
ence of Ca2. Although antibody or peptide injection experi-
ments in neurons or endocrine cells have clearly demonstrated
the importance of the C2 domains in synaptic vesicle tra⁄ck-
ing [35^42], there is no direct evidence as to whether the
above-mentioned protein^protein interactions, especially the
C2B domain^protein interactions, are essential in vivo.
To examine the in vivo signi¢cance of C2B domain^protein
interactions, we focused on the Drosophila AD3 mutation, in
which there is a Tyr-364 to Asn substitution in the C2B do-
main [43,44]. This syt allele is homozygous lethal but comple-
ments another mutant phenotype [43,44], and thus it has been
suggested that Syt I functions in an oligomerized state in
neurotransmitter release. However, although it was expected
that certain C2B^protein interactions would be impaired, it
remains unknown why such a mutation abrogates the func-
tion of Syt. To address this, we introduced a similar mutation
into mouse Syt II, a homologue of Drosophila Syt I, which is
predominantly expressed in the caudal region of the mamma-
lian brain, and examined the e¡ect of the Tyr-312 to Asn
(Y312N) mutation of mouse Syt II on Ca2-dependent self-
oligomerization properties [28^34]. We showed that Y312N
mutation impairs Ca2-dependent self-oligomerization activ-
ity, and based on this ¢nding, we discuss the importance of
Ca2-dependent oligomerization of the C2B domain in neuro-
transmitter release
2. Materials and methods
2.1. Materials
AmpliTaq DNA polymerase and restriction enzymes were obtained
from PE Biosystems (Foster City, CA, USA) and Toyobo Biochem-
icals (Tokyo, Japan), respectively. Polyclonal antibody against FLAG
peptide was obtained from Zymed Laboratories Inc. (San Francisco,
CA, USA). Horseradish peroxidase (HRP)-conjugated anti-T7 tag
antibody was from Novagen (Madison, WI, USA). D/L-myo-inositol
1,3,4,5-tetrakisphosphate (IP4) was purchased from Dojindo Labora-
tories (Kumamoto, Japan). All other chemicals were commercial
products of reagent grade. Solutions were made up in deionized water
prepared with an Elix10 Water Puri¢cation System and Milli-Q Biocel
A10 System (Millipore Corp.; Bedford, MA, USA).
2.2. Expression constructs and mutagenesis
A mutant Syt II carrying a Y312N mutation was essentially pro-
duced by means of two-step polymerase chain reaction techniques as
described previously [16] by using the following oligonucleotides: 5P-
CCAACGTTAAGATCCACCTGATGCAGAACG-3P (sense; amino
acid residues 311^321) and 5P-CTTAACGTTGGGGTCTGAAAG-
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GCCCCC-3P (antisense; amino acid residues 306^314) (AclI, under-
lined). The resulting Syt II cytoplasmic fragment carrying the Y312N
mutation was subcloned into the NotI site of pEF-BOS (named pEF-
T7- or FLAG-Syt II (Y312N)-cyto [12,45]. Other expression con-
structs (pEF-T7- or FLAG-Syt II-cyto, -Syt II (KQ)-cyto) were pre-
pared as described previously [12,16,33].
2.3. Miscellaneous procedures
Co-transfection of pEF-T7-Syts and pEF-FLAG-Syts into COS-7
cells (5U105 cells, the day before transfection/10 cm dish) was carried
out by the DEAE-dextran method as described previously [33,46,47]
or by using the LipofectAmine Plus reagent according to the manu-
facturer’s notes (Life Technologies, Rockville, MD, USA). Three days
after transfection, cells were harvested, and the proteins were solubi-
lized with bu¡er containing 1% Triton X-100, 250 mM NaCl, 50 mM
HEPES^KOH, pH 7.2, 0.1 mM phenylmethylsulfonyl £uoride, 10 WM
leupeptin, and 10 WM pepstatin A at 4‡C for 1 h. Immunoprecipita-
tion of T7-Syts in the presence or absence of 250 WM (or 500 WM)
Ca2 by anti-T7 tag antibody-conjugated agarose, SDS^polyacryl-
amide gel (10%) electrophoresis, and immunoblotting analyses were
also performed as described previously [46]. Immunoreactive bands
were captured by Gel Print 2000i/VGA (Bio Image) and quanti¢ed
by Basic Quanti¢er Software (version 1.0) (Bio Image).
3. Results and discussion
3.1. Tyr-334 of Drosophila Syt I is one of the highly conserved
residues among the Syt C2 domains
The Drosophila AD3 allele contains a Tyr to Asn substitu-
tion at amino acid position 334 within the C2B domain. This
tyrosine residue is highly conserved during evolution, among
other Syt isoforms [19,46], and even between the C2A and
C2B domains (Fig. 1). Recent crystallographic analysis of
the cytoplasmic portion of Syt III indicates that both C2
domains exhibit a similar overall structure, although they
show di¡erences in the shape of the Ca2 binding pocket,
the electrostatic surface potential, and the stoichiometry of
bound divalent cations [48]: eight-stranded L-sandwiches
with type I C2 topology and Ca2 binding loops at the apex
of the fold formed by the L-sandwiches. The Tyr-334 of Dro-
sophila Syt I lies on the L-3 strand in the vicinity of the
putative Ca2 binding loop. Interestingly, the sequences sur-
rounding Tyr-334 (SDPYVK) are also highly conserved dur-
ing evolution, as well as between tandem C2 domains (Fig. 1).
When the PYVK sequence of the C2A domain of Syt II was
deleted, Ca2-dependent phospholipid binding activity was
completely abolished [14]. Therefore, the PYVK sequence of
the C2B domain is also expected of being involved in certain
Ca2-dependent processes, although the C2B domain of Syt I
or II itself did not show Ca2-dependent phospholipid binding
activity [12]. Since most ligands bind the C2B domain in a
Ca2-independent manner [12,20,24,27], we ¢rst attempted to
determine whether the Y312N mutation of mouse Syt II, cor-
responding to the Drosophila AD3 mutation, a¡ects a Ca2-
independent process, i.e. Ca2-independent IP4 binding to the
mutant C2B domain. However, since the mutant Syt II pro-
teins still bound IP4 well (data not shown), we then investi-
gated a possible involvement of the conserved Tyr in a Ca2-
dependent process, i.e. Ca2-dependent self-oligomerization
properties [28^34].
Fig. 1. Alignment of the L-3 and L-4 strands of the two C2 domains
of Drosophila and mouse Syts. Residues that have been conserved
in all sequences are shown on a black background. Note that the
SDPYVK sequence is highly conserved between the two C2 do-
mains as well as between Drosophila and vertebrate Syts. The aster-
isk indicates the position of the Drosophila AD3 mutation [43,44].
The number signs (#) indicate the position of the Lys residues that
are only conserved in the C2B domain [16] and are essential for IP4
binding, AP-2 binding, and self-oligomerization (so-called ‘C2B ef-
fector domain’) [31]. Arrows indicate the L-strands [48]. Amino acid
substitutions of Syt II are indicated by arrowheads. Amino acid
numbers are indicated on the right.
Fig. 2. E¡ect of Y312N mutation on self-oligomerization of mouse
Syt II. pEF-T7-Syts-cyto and pEF-FLAG-Syts-cyto were co-trans-
fected into COS-7 cells. A: Expressed proteins were solubilized with
1% Triton X-100 and immunoprecipitated by anti-T7 tag antibody-
conjugated agarose as described previously [46]. Co-immunoprecipi-
tated FLAG-Syts were ¢rst detected with anti-FLAG rabbit anti-
body (5 Wg/ml; upper panel). The same blot was then stripped and
reprobed with HRP-conjugated anti-T7 tag antibody to ensure that
the same amounts of T7-tagged proteins were loaded (1/1000 dilu-
tion; lower panel). The positions of the molecular weight markers
(U1033) are shown on the left. B: Immunoreactive bands were cap-
tured by Gel Print 2000i/VGA and quanti¢ed by Basic Quanti¢er
software. Bars indicate the S.D. of three independent experiments.
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3.2. Essential role of Tyr-312 in Ca2+-dependent
self-oligomerization of mouse Syt II
As shown in Fig. 1 (bottom), we produced two Syt II mu-
tants: a Y312N mutant corresponding to the Drosophila AD3
mutation and a KQ mutant, as a negative control, with a
mutated C2B e¡ector domain located at the L-4 strand
[16,31]. This KQ mutant impairs AP-2 binding, IP4 binding,
and self-oligomerization activity [16,31,49]. The Ca2-depen-
dent self-oligomerization activities were assayed by co-trans-
fection of T7- and FLAG-Syts as described previously [33,46].
Brie£y, T7- and FLAG-Syt II-cyto were co-expressed in COS-
7 cells, and the association between FLAG-Syt and T7-Syt
immunoprecipitants was evaluated by immunoblotting. The
self-oligomerization activity of wild-type Syt II was activated
by 500 WM Ca2 (approximately a 2-fold increase; Fig. 2A,B).
By contrast, both Y312N (AD3) and KQ mutants completely
abolished the Ca2-activated self-oligomerization activity, and
the Ca2-independent self-oligomerization activity was also
dramatically reduced (Fig. 2A, lanes 5^8). The lack of Ca2-
dependent self-oligomerization of these mutants was not due
to the protein stability or protein expression levels, because
equivalent amounts of proteins were recovered in cell lysates
when compared to wild-type proteins (data not shown). Inter-
estingly, however, the interaction of the AD3 mutant with
wild-type proteins was signi¢cantly activated by Ca2 (ap-
proximately a 2-fold increase; Fig. 2A, lanes 3 and 4). This
¢nding indicates that the Y312N mutant can partially interact
with the intact C2B domain of other mutant proteins, which is
consistent with the fact that the AD3 allele can complement
other mutant phenotypes [43,44]. Therefore, one attractive
explanation for the ability of the AD3 allele to compensate
other mutant phenotypes is that the C2B domain carrying the
AD3 mutation can only act as an acceptor for Ca2-depen-
dent oligomerization.
We recently showed that Ca2-dependent self-oligomeriza-
tion mediated by the Syt II C2B domain can occur e⁄ciently
when the two molecules are tethered at the N-terminal do-
main (i.e. Ca2-independent oligomerization) [33]. Since the
full-length Y312N mutant Syt II proteins normally associate
with wild-type proteins at the N-terminal domain (data not
shown), Ca2-dependent oligomerization of the AD3 mutant
with the wild-type C2B domain is expected to occur more
e⁄ciently than shown in Fig. 2, where the Syt II cytoplasmic
domain was used (see also Fig. 4).
3.3. Inhibition of self-oligomerization of mouse Syt II by IP4
We previously identi¢ed Syts I and II as IP4 binding pro-
teins in the central nervous system [12,50] and have shown
that binding of IP4 to their C2B domains blocks transmitter
secretion in squid giant synapses, superior cervical ganglion
neurons, and chroma⁄n cells [38^40]. However, the detailed
molecular mechanism remains largely unknown (i.e. disrup-
tion of speci¢c protein^C2B domain interaction by IP4). To
examine the possible involvement of IP4 in self-oligomeriza-
tion, we measured the self-oligomerization activity of Syt II-
cyto in the presence and absence of 10 WM IP4. As shown in
Fig. 3, IP4 signi¢cantly reduced the Ca2-dependent oligomer-
ization activity, whereas Ca2-independent oligomerization
activity was una¡ected. Therefore, it is likely that the blocking
of transmitter secretion by IP4 is attributable to disruption of
self-oligomerization of the C2B domain.
3.4. Conclusion
In the present study, we ¢rst found that the Y312N mutant
of Syt II, which corresponds to the Drosophila AD3 mutation,
impairs Ca2-dependent self-oligomerization activity, but that
it can act as an acceptor for Ca2-dependent hetero-oligomer-
ization with wild-type protein, indicating that the abnormal
Fig. 3. E¡ect of IP4 on self-oligomerization of mouse Syt II. pEF-
T7-Syt II-cyto and pEF-FLAG-Syt II-cyto were co-transfected into
COS-7 cells. A: Expressed proteins were solubilized with 1% Triton
X-100 and immunoprecipitated with anti-T7 tag antibody-conju-
gated agarose in the presence and absence of 250 WM Ca2 and/or
10 WM IP4 [46]. Co-immunoprecipitated FLAG-Syts were ¢rst de-
tected by anti-FLAG rabbit antibody (5 Wg/ml; upper panel). Then,
the same blot was stripped and reprobed with HRP-conjugated
anti-T7 tag antibody to ensure that the same amounts of T7-tagged
proteins were loaded (1/1000 dilution; lower panel). The positions
of the molecular weight markers (U1033) are shown on the right.
B: Immunoreactive bands were captured by Gel Print 2000i/VGA
and quanti¢ed by Basic Quanti¢er software. Bars indicate the S.D.
of two or three independent experiments.
Fig. 4.
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transmitter release in the AD3 Drosophila mutant probably
results from a lack of self-oligomerization capacity (summa-
rized in Fig. 4). Although almost all of the C2B ligands re-
quire the C2B e¡ector domain (Lys cluster), we speculate that
the Y312 of Syt II is a speci¢c residue necessary for Ca2-
dependent self-oligomerization but not for the binding of oth-
er Ca2-independent ligands, including IP4. We also found
that the Ca2-dependent C2B self-oligomerization was inhib-
ited by IP4, a potent inhibitor of neurotransmitter release [51].
All of these ¢ndings strongly support the idea that self-oligo-
merization of Syts I and II is essential for neurotransmitter
release in vivo.
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